Healthcare IT Today
JANUARY 8, 2024
As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. Drug developers can use these tools to inform routine information-discovery tasks that would require much more time for humans to execute, including benefits-risk evaluation and safety assessments. Dave Latshaw, CEO at BioPhy 1.
Lloyd Price
MAY 30, 2024
As AI technology becomes more integrated into medical practices, healthcare organisations are looking for leaders to develop strategy and implementation, effectively communicate the benefits and risks of AI to all stakeholders and oversee the development and use of AI to ensure it is fair, unbiased, and adheres to patient privacy regulation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
NOVEMBER 21, 2023
Exec Summary: To win the hearts and minds of the public in England and successfully deliver the NHS Federated Data Platform (FDP), Palantir should focus on the following strategies: Address Privacy Concerns: Public trust is paramount, particularly when dealing with sensitive patient data. Email lloyd@nelsonadvisors.co.uk Subscribe Today!
Society for Participatory Medicine
FEBRUARY 1, 2023
The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.
Lloyd Price
MAY 2, 2024
Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. To support their strategy, Nvidia recently acquired both Deci and Run AI, making a significant move in the AI landscape.
Lloyd Price
APRIL 27, 2024
It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. By using this technology in innovative ways, healthcare organisations can improve patient care, reduce costs, and accelerate the development of new treatments. Visit www.nelsonadvisors.co.uk Subscribe Today!
Lloyd Price
APRIL 22, 2024
Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.
Expert insights. Personalized for you.
96 
Let's personalize your content